DV Trading’s Dianthus Therapeutics DNTH Stock Holding History

DV Trading’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,551	Closed	-$2.23M	–	583
2026 Q1	$2.23M	Buy	+26,551	New	+$1.54M	0.05%	102

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

DV Trading's DNTH Position: Q2 2026 in Review

DV Trading sold out of Dianthus Therapeutics (DNTH) in Q2 2026, closing a stake of 26,551 shares — an estimated $2.23M sold.

DV Trading first reported a position in DNTH in Q1 2026 and held it in 1 quarter. The position peaked at $2.23M in Q1 2026. 267 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

DV Trading reported no remaining Dianthus Therapeutics position as of Q2 2026 after selling out during the quarter.
DV Trading sold 26,551 Dianthus Therapeutics shares in Q2 2026, an estimated $2.23M.
DV Trading first reported a position in Dianthus Therapeutics in Q1 2026 and held it in 1 quarter.
DV Trading's Dianthus Therapeutics position peaked at $2.23M in Q1 2026.
267 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.